DLK1 and kidney disorder: In contrast, there were no differences in the expression of the NOTCH-1 canonical ligand and activator, Jagged-1 involved in experimental kidney fibrosis [33,34], and in the mRNA levels of the noncanonical ligand Dlk-1, an endogenous inhibitor re-expressed in kidney diseases [35] (Figure 4C-D).